Metabolic-associated fatty liver disease raises risk of end-stage renal disease Dr. Kamal Kant Kohli9 Nov 2022 10:45 AM ISTCHINA: According to research reported in Acta Diabetologica, individuals with biopsy-proven diabetic nephropathy are at an increased risk of incident...
Nonpapillary prone endoscopic combined intrarenal surgery accomplishes better "stone-free-rate" and fewer complications Aditi8 Nov 2022 9:30 AM ISTGreece: Nonpapillary prone Endoscopic Combined Intrarenal Surgery (ECIRS) has proven safety and effectiveness with good stone-free-rate and outcomes,...
Among males, two weeks antibiotics course good enough for febrile UTIs with normal PSA Dr.Niharika Harsha B6 Nov 2022 8:00 PM ISTNew research found that prostate involvement was not evidently seen in nearly one-fifth of men who had febrile urinary tract infections. The study was...
Long term exposure to air pollution increases risk of developing CKD Dr. Kamal Kant Kohli6 Nov 2022 7:00 PM ISTChronic kidney disease (CKD) is a global disease burden related to high rates of incidence and mortality. It manifests as progressive and...
Fluoxetine effective and safe in children with refractory Nocturnal Enuresis, Recommends study Aditi5 Nov 2022 12:15 PM ISTEgypt: A study published in the Journal of Urology has concluded the safety of Fluoxetine, which is a selective serotonin reuptake inhibitor, SSRI in...
Dapagliflozin effective from clinical standpoint as well as cost standpoint for CKD patients Dr. Kamal Kant Kohli5 Nov 2022 9:30 AM ISTThe burden of chronic kidney disease (CKD) to both healthcare systems and patients is considerable. Dapagliflozin, a sodium-glucose cotransporter-2...
Novel drug gepotidacin for uncomplicated UTI meets trial goals Dr. Kamal Kant Kohli4 Nov 2022 10:00 PM ISTPharmaceutical giant Glaxo Smith Kline has announced today that two clinical trials for an investigational antibiotic gepotidacin for use in...
Metastasectomy in renal cell carcinoma patients when and how? Jacinthlyn Sylvia3 Nov 2022 8:00 PM ISTMetastatic renal cell carcinoma has a variable natural history. Therefore treatment choice depends on disease and patient factors, but most...
Is it time to revise standard cut off of 300 ng/dL for testosterone deficiency in young men? Medha Baranwal1 Nov 2022 7:30 PM ISTUSA: A recent study in the Journal of Urology has suggested that age-specific testosterone cutoffs and reference ranges should be used for evaluating...
Coffee consumption may prolong prostate cancer-specific survival, study finds Medha Baranwal1 Nov 2022 11:15 AM ISTUSA: In a large study published in European Urology Oncology, coffee consumption in men with prostate cancer and fast caffeine metabolism are...
Urine bicarbonate test offers new, safe quantification of CFTR function in cystic fibrosis patients Dr. Kamal Kant Kohli1 Nov 2022 9:30 AM ISTA study of 50 adult patients with cystic fibrosis (CF) has found that challenged urine bicarbonate excretion may offer a new, simple, and safe...
Ticagrelor-aspirin antiplatelet therapy more beneficial in persons with normal renal function Dr. Kamal Kant Kohli1 Nov 2022 2:45 AM ISTAn analysis of the CHANCE-2 trial has found that persons with normal renal function receive greater benefit from antiplatelet therapy with...
